Sharon B. Cantor

7.2k total citations · 2 hit papers
49 papers, 4.5k citations indexed

About

Sharon B. Cantor is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Sharon B. Cantor has authored 49 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 15 papers in Oncology and 15 papers in Genetics. Recurrent topics in Sharon B. Cantor's work include DNA Repair Mechanisms (46 papers), CRISPR and Genetic Engineering (14 papers) and BRCA gene mutations in cancer (13 papers). Sharon B. Cantor is often cited by papers focused on DNA Repair Mechanisms (46 papers), CRISPR and Genetic Engineering (14 papers) and BRCA gene mutations in cancer (13 papers). Sharon B. Cantor collaborates with scholars based in United States, United Kingdom and Netherlands. Sharon B. Cantor's co-authors include David M. Livingston, Takeshi Urano, Larry A. Feig, Min Peng, Robert M. Brosh, Shawna Guillemette, Ronny Drapkin, Sudha Sharma, Joshua A. Sommers and Fan Zhang and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Sharon B. Cantor

48 papers receiving 4.4k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function

2001 541 citations Sharon B. Cantor, Ronny Drapkin et al. Cell profile →
Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency

2021 229 citations Ke Cong, Min Peng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharon B. Cantor United States	31	4.2k	1.1k	1.1k	926	418	49	4.5k
Petr Ćejka Switzerland	42	6.1k 1.4×	515 0.5×	1.4k 1.2×	1.0k 1.1×	511 1.2×	99	6.4k
Frédéric Coin France	36	3.8k 0.9×	603 0.5×	660 0.6×	733 0.8×	205 0.5×	65	4.1k
Zoë Weaver Ohler United States	20	2.0k 0.5×	929 0.8×	1.0k 0.9×	465 0.5×	350 0.8×	41	2.7k
Zuzana Hořejšı́ United Kingdom	16	3.3k 0.8×	339 0.3×	1.6k 1.4×	674 0.7×	489 1.2×	19	3.8k
Kristen E. Hurov United States	12	4.0k 0.9×	362 0.3×	1.4k 1.2×	722 0.8×	607 1.5×	22	4.3k
Julia Coates United Kingdom	19	4.3k 1.0×	424 0.4×	1.6k 1.4×	712 0.8×	538 1.3×	22	4.5k
Chi‐Fen Chen United States	22	2.5k 0.6×	1.1k 1.0×	657 0.6×	337 0.4×	389 0.9×	39	3.0k
Franck Toledo France	22	2.5k 0.6×	530 0.5×	1.6k 1.4×	594 0.6×	241 0.6×	45	3.2k
Amom Ruhikanta Meetei United States	25	3.1k 0.7×	602 0.5×	448 0.4×	863 0.9×	450 1.1×	42	3.2k

Countries citing papers authored by Sharon B. Cantor

Since Specialization

Citations

This map shows the geographic impact of Sharon B. Cantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon B. Cantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon B. Cantor more than expected).

Fields of papers citing papers by Sharon B. Cantor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon B. Cantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon B. Cantor. The network helps show where Sharon B. Cantor may publish in the future.

Co-authorship network of co-authors of Sharon B. Cantor

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon B. Cantor. A scholar is included among the top collaborators of Sharon B. Cantor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon B. Cantor. Sharon B. Cantor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mercurio, Arthur M., et al.. (2025). Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerability. Nature Cancer. 6(2). 278–291. 5 indexed citations

Dash, Radha Charan, S J James, Marcello Stanzione, et al.. (2024). Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction. Bioorganic & Medicinal Chemistry. 106. 117755–117755. 3 indexed citations

Cong, Ke, Jennifer A. Calvo, Min Peng, et al.. (2024). FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells. Nature Communications. 15(1). 2599–2599. 14 indexed citations

Cantor, Sharon B., et al.. (2024). Positioning loss of PARP1 activity as the central toxic event in BRCA-deficient cancer. DNA repair. 144. 103775–103775. 4 indexed citations

Calvo, Jennifer A., Briana Fritchman, Desiree Hernandez, et al.. (2021). Comprehensive Mutational Analysis of the BRCA1-Associated DNA Helicase and Tumor-Suppressor FANCJ/BACH1/BRIP1. Molecular Cancer Research. 19(6). 1015–1025. 13 indexed citations

Lee, Wei Ting C., Yandong Yin, Michael J. Morten, et al.. (2021). Single-molecule imaging reveals replication fork coupled formation of G-quadruplex structures hinders local replication stress signaling. Nature Communications. 12(1). 2525–2525. 68 indexed citations

Sommers, Joshua A., Arindam Datta, Sumeet U. Nayak, et al.. (2020). FANCJ compensates for RAP80 deficiency and suppresses genomic instability induced by interstrand cross-links. Nucleic Acids Research. 48(16). 9161–9180. 8 indexed citations

Cantor, Sharon B. & Jennifer A. Calvo. (2017). Fork Protection and Therapy Resistance in Hereditary Breast Cancer. Cold Spring Harbor Symposia on Quantitative Biology. 82. 339–348. 12 indexed citations

Wang, Yue, Matthew Ung, Sharon B. Cantor, & Chao Cheng. (2017). Computational Investigation of Homologous Recombination DNA Repair Deficiency in Sporadic Breast Cancer. Scientific Reports. 7(1). 15742–15742. 10 indexed citations

10.

Cantor, Sharon B. & Sumeet U. Nayak. (2016). FANCJ at the FORK. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 788. 7–11. 8 indexed citations

11.

Peng, Min, et al.. (2014). Crosstalk between BRCA ‐ F anconi anemia and mismatch repair pathways prevents MSH 2‐dependent aberrant DNA damage responses. The EMBO Journal. 33(15). 1698–1712. 44 indexed citations

12.

Guillemette, Shawna, et al.. (2013). FANCJ Localization by Mismatch Repair Is Vital to Maintain Genomic Integrity after UV Irradiation. Cancer Research. 74(3). 932–944. 24 indexed citations

13.

Suhasini, Avvaru N., Yuliang Wu, Joshua A. Sommers, et al.. (2011). Interaction between the helicases genetically linked to Fanconi anemia group J and Bloom's syndrome. The EMBO Journal. 30(4). 692–705. 81 indexed citations

14.

Xie, Jenny, Shawna Guillemette, Min Peng, et al.. (2010). An MLH1 Mutation Links BACH1/FANCJ to Colon Cancer, Signaling, and Insight toward Directed Therapy. Cancer Prevention Research. 3(11). 1409–1416. 16 indexed citations

15.

Sommers, Joshua A., Rigu Gupta, Dmitry V. Bugreev, et al.. (2009). FANCJ Uses Its Motor ATPase to Destabilize Protein-DNA Complexes, Unwind Triplexes, and Inhibit RAD51 Strand Exchange. Journal of Biological Chemistry. 284(12). 7505–7517. 94 indexed citations

16.

Barber, Louise J., Jillian L. Youds, Jordan D. Ward, et al.. (2008). RTEL1 Maintains Genomic Stability by Suppressing Homologous Recombination. Cell. 135(2). 261–271. 298 indexed citations

17.

Gupta, Rigu, et al.. (2008). BRCA-FA Pathway as a Target for Anti-Tumor Drugs. Anti-Cancer Agents in Medicinal Chemistry. 8(4). 426–430. 19 indexed citations

18.

Gupta, Rigu, Sudha Sharma, Kevin M. Doherty, et al.. (2006). Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand. Nucleic Acids Research. 34(22). 6673–6683. 36 indexed citations

19.

Greenberg, Roger A., Bijan Sobhian, Shailja Pathania, et al.. (2006). Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. Genes & Development. 20(1). 34–46. 245 indexed citations

20.

Cantor, Sharon B., Ronny Drapkin, Fan Zhang, et al.. (2004). The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations. Proceedings of the National Academy of Sciences. 101(8). 2357–2362. 193 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact